P268S in NOD2 associates with susceptibility to Parkinson’s disease in Chinese population

[1]  Zhiming Li,et al.  P268S in NOD2 associates with susceptibility to Parkinson’s disease in Chinese population , 2013, Behavioral and Brain Functions.

[2]  Xiaoming Yang,et al.  Confirmation of three inflammatory bowel disease susceptibility loci in a Chinese cohort , 2012, International Journal of Colorectal Disease.

[3]  M. Nalls,et al.  Genetic variability at the PARK16 locus , 2010, European Journal of Human Genetics.

[4]  Yih-Ru Wu,et al.  Genetic analysis of Parkin in early onset Parkinson's disease (PD): Novel intron 9 g > a single nucleotide polymorphism and risk of Taiwanese PD , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[5]  羅 芳宜,et al.  Alteration of PAFAH1B1 in Human Lung Cancer and Its Roles in Tumor Progression and Poor Survival , 2010 .

[6]  E. Hirsch,et al.  Neuroinflammation in Parkinson's disease: a target for neuroprotection? , 2009, The Lancet Neurology.

[7]  A. Fleig,et al.  SLC41A1 Is a Novel Mammalian Mg2+ Carrier* , 2008, Journal of Biological Chemistry.

[8]  J. Burgunder,et al.  LRRK2 Gly2385Arg variant is a risk factor of Parkinson’s disease among Han‐Chinese from mainland China , 2008, European journal of neurology.

[9]  A. Lang,et al.  Deciphering the role of heterozygous mutations in genes associated with parkinsonism , 2007, The Lancet Neurology.

[10]  F. Mastaglia,et al.  Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's Disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[11]  G. Opala,et al.  CARD15 variants in patients with sporadic Parkinson's disease , 2007, Neuroscience Research.

[12]  N. Hattori,et al.  Leucine-Rich Repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population , 2007, Neuroreport.

[13]  N. Quinn,et al.  A heterozygous effect for PINK1 mutations in Parkinson's disease? , 2006, Annals of neurology.

[14]  T. Joh,et al.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease , 2006, Experimental & Molecular Medicine.

[15]  T. Gillis,et al.  Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. , 2006, Archives of neurology.

[16]  Matthew J. Farrer,et al.  LRRK2 in Parkinson's disease: protein domains and functional insights , 2006, Trends in Neurosciences.

[17]  C. Klein.  Implications of genetics on the diagnosis and care of patients with Parkinson disease. , 2006, Archives of neurology.

[18]  N. Hattori,et al.  Diverse Effects of Pathogenic Mutations of Parkin That Catalyze Multiple Monoubiquitylation in Vitro* , 2006, Journal of Biological Chemistry.

[19]  M. Farrer,et al.  The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients , 2005, Neuroscience Letters.

[20]  J. Si,et al.  [NOD2/CARD15 gene polymorphisms and susceptibility to Crohn's disease in Chinese Han population]. , 2005, Zhonghua nei ke za zhi.

[21]  Zhenxin Zhang,et al.  Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai , 2005, The Lancet.

[22]  E. Eriksson,et al.  Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[23]  P. Mcgeer,et al.  Inflammation and neurodegeneration in Parkinson's disease. , 2004, Parkinsonism & related disorders.

[24]  P. Lockhart,et al.  Parkin genetics: one model for Parkinson's disease. , 2004, Human molecular genetics.

[25]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[26]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[27]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[28]  D. Jewell,et al.  NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population , 2003, Alimentary pharmacology & therapeutics.

[29]  S. Fahn.  Description of Parkinson's Disease as a Clinical Syndrome , 2003, Annals of the New York Academy of Sciences.

[30]  J. Hugot,et al.  Gene–environment interaction modulated by allelic heterogeneity in inflammatory diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[32]  Judy H. Cho,et al.  Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. , 2003, Gastroenterology.

[33]  K. Huse,et al.  Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations , 2003, European Journal of Human Genetics.

[34]  Yusuke Nakamura,et al.  Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease , 2002, Journal of Human Genetics.

[35]  Tony Wyss-Coray,et al.  Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.

[36]  L. Bradbury,et al.  Role of NOD2 variants in spondylarthritis. , 2002, Arthritis and rheumatism.

[37]  K. Marder,et al.  Evaluation of 50 probands with early-onset Parkinson’s disease for Parkin mutations , 2002, Neurology.

[38]  C. Kaltschmidt,et al.  Stimulus-dependent activation of NF-κB specifies apoptosis or neuroprotection in cerebellar granule cells , 2002, NeuroMolecular Medicine.

[39]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[40]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[41]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[42]  Bonifati,et al.  Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.

[43]  J. Woo,et al.  The α-Synuclein Gene and Parkinson Disease in a Chinese Population , 2000 .

[44]  J. Woo,et al.  The alpha-synuclein gene and Parkinson disease in a Chinese population. , 2000, Archives of neurology.

[45]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[46]  Y Agid,et al.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[48]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[49]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[50]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[51]  T. Nagatsu.  [Biochemistry of Parkinson's disease]. , 1988, Seikagaku. The Journal of Japanese Biochemical Society.